Berkeley Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$9.96M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91M |
| 3 |
Sysco
SYY
|
+$1.32M |
| 4 |
RTX Corp
RTX
|
+$1.26M |
| 5 |
Citigroup
C
|
+$1.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$1.52M |
| 2 |
Mondelez International
MDLZ
|
+$1.26M |
| 3 |
Medtronic
MDT
|
+$889K |
| 4 |
Merck
MRK
|
+$747K |
| 5 |
Conagra Brands
CAG
|
+$703K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.86% |
| 2 | Financials | 4.27% |
| 3 | Consumer Staples | 3.63% |
| 4 | Healthcare | 3.55% |
| 5 | Consumer Discretionary | 3.38% |
Similar funds
Berkeley Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Berkeley Capital Partners held 181 positions worth $360M, up 2.7% from $350M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Berkeley Capital Partners deployed $16.4M of net new capital in Q4 2024, opening 17 new positions and adding to 83 existing holdings. Its largest new stake was Invesco QQQ Trust: 19,696 shares worth $10.1M.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.8% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Morgan Stanley, an estimated $1.52M trimmed.
- Berkeley Capital Partners's largest Q4 2024 buy was Invesco QQQ Trust: 19,696 shares worth $10.1M.
- Berkeley Capital Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $2.91M increase.
- Berkeley Capital Partners's biggest Q4 2024 reduction was Morgan Stanley, cutting an estimated $1.52M.
- Berkeley Capital Partners fully exited Mondelez International in Q4 2024, selling an estimated $1.26M.
- Berkeley Capital Partners's ten largest holdings make up 52% of its $360M portfolio in Q4 2024.
- Berkeley Capital Partners opened 17 new positions and closed 7 in Q4 2024.
- Berkeley Capital Partners's portfolio value rose 2.7% quarter-over-quarter to $360M.
Based on Berkeley Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.